Clinical Trial Update: Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis [Phase 2]

View source ↗

Summary

This update notes the completion of a Phase 2, controlled study of ONO-5334 in postmenopausal women with osteopenia or osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia
• Osteoporosis

Drugs mentioned

• ONO-5334 (ONO-5334)

Snippet

Sponsor: Ono Pharma USA Inc | Conditions: Osteoporosis, Osteopenia | Phase 2 | Status: COMPLETED